Varian Medical
Systems VAR and Paul Scherrer Institute (PSI) are announcing a
collaboration to further advance motion management techniques for proton
therapy. The multi-year agreement, aimed at optimizing treatment strategies
for indications such as cancer in the lung, liver, pancreas and breast, will
evaluate strategies using a 4-D treatment planning simulator developed by PSI.
Proton therapy involves the use of a controlled beam of protons to target
tumors with higher levels of precision than is possible with other forms of
radiation therapy, potentially limiting damage to healthy surrounding tissue.
The Paul Scherrer Institute in Switzerland is a pioneer in the development of
Intensity Modulated Proton Therapy (IMPT) techniques, and specializes in the
treatment of pediatric patients. "We hope to exploit our unique methods for
simulating clinically realistic organ motions for the study of motion
mitigation techniques for spot scanned proton therapy," says Professor Tony
Lomax from PSI. "This project will utilize 4-D motion data sets and dose
calculations that can uniquely model patient motion variations that are
difficult to capture with conventional data sets."
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Posted In: News
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in